Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review
Abstract
Objective: To assess the effectiveness and safety of antiplatelet drugs for prevention of pre-eclampsia and its consequences. Design: Systematic review. Data sources: Register of trials maintained by Cochrane Pregnancy and Childbirth Group, Cochrane Controlled Trials Register, and Embase. Included studies: Randomised trials involving women at risk of pre-eclampsia, and its complications, allocated to antiplatelet drug(s) versus placebo or no antiplatelet drug. Main outcomes measures: Pre-eclampsia, preterm birth, fetal or neonatal death, and small for gestational age baby. Studies were assessed for quality of concealment of allocation and losses to follow up. Results: 39 trials (30 563 women) were included, and 45 trials (>3000 women) excluded. Use of antiplatelet drugs was associated with a 15% reduction in the risk of pre-eclampsia (32 trials, 29 331 women; relative risk 0.85, 95% confidence interval 0.78 to 0.92; number needed to treat 100, 59 to 167). There was also an 8% reduction in the risk of preterm birth (23 trials, 28 268 women; 0.92, 0.88 to 0.97; 72, 44 to 200), and a 14% reduction in the risk of fetal or neonatal death (30 trials, 30 093 women; 0.86, 0.75 to 0.98; 250, 125 to >10 000) for women allocated antiplatelet drugs. Small for gestational age babies were reported in 25 trials (20 349 women), with no overall difference between the groups (relative risk 0.92, 0.84 to 1.01). There were no significant differences in other measures of outcome. Conclusions: Antiplatelet drugs, largely low dose aspirin, have small to moderate benefits when used for prevention of pre-eclampsia.Keywords
This publication has 16 references indexed in Scilit:
- Bias in meta-analysis detected by a simple, graphical testBMJ, 1997
- A meta‐analysis of low dose aspirin for the prevention of intrauterine growth retardationBJOG: An International Journal of Obstetrics & Gynaecology, 1997
- Where next for prophylaxis against pre‐eclampsia?BJOG: An International Journal of Obstetrics & Gynaecology, 1996
- Multicentre trials in obstetrics and gynaecologyBJOG: An International Journal of Obstetrics & Gynaecology, 1996
- Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancyBJOG: An International Journal of Obstetrics & Gynaecology, 1995
- Misleading meta-analysisBMJ, 1995
- Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the CaribbeanBJOG: An International Journal of Obstetrics & Gynaecology, 1992
- Aspirin for Prevention of Pregnancy-Induced HypertensionMCN: The American Journal of Maternal/Child Nursing, 1992
- Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy.1988
- MATERNAL VASCULAR PROSTACYCLIN ACTIVITY IN PRE-ECLAMPSIAThe Lancet, 1980